Citation Impact

Citing Papers

Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance
2011
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Conversion of Th2 memory cells into Foxp3 + regulatory T cells suppressing Th2-mediated allergic asthma
2010
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells
2008 StandoutNobel
Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class II
2008
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
The alarmin IL-33 promotes regulatory T-cell function in the intestine
2014 Nature
Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses
2016
Cancer stem cells: implications for the progression and treatment of metastatic disease
2007
Regulation and function of mTOR signalling in T cell fate decisions
2012
mTOR Signaling in Growth Control and Disease
2012 Standout
Crystal Structure of the Murine Cytomegalovirus MHC-I Homolog m144
2006
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway
2008
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Tumor-associated macrophages in cancers
2015
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Antigen- and Cytokine-Driven Accumulation of Regulatory T Cells in Visceral Adipose Tissue of Lean Mice
2015
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
2010
Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis
2009
Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells
2016
Tolerogenic dendritic cells and the quest for transplant tolerance
2007
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
2010
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The role of mTOR in memory CD8+ T‐cell differentiation
2010
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
Regulation of innate immune cell function by mTOR
2015
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
2005 Standout
mTOR: taking cues from the immune microenvironment
2009
Malignant Gliomas in Adults
2008 Standout
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Molecular phenotype of airway side population cells
2004
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
2010
Hematopoietic Stem-Cell Transplantation
2006 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
2019
Induction of T cell anergy: integration of environmental cues and infectious tolerance
2010
Rheumatoid arthritis
2010 Standout
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
The plasticity and stability of regulatory T cells
2013 StandoutNobel
What We Talk About When We Talk About Fat
2014 Standout
Neural progenitor genes
2003
AKT/PKB Signaling: Navigating the Network
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme
2004
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Mutations Designed to Destabilize the Receptor-Bound Conformation Increase MICA-NKG2D Association Rate and Affinity
2007 StandoutNobel
Rapamycin unbalances the polarization of human macrophages to M1
2013
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
2008 StandoutNobel
Tissue Tregs
2016
Tumour stem cells and drug resistance
2005 Standout
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances
2012
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
Regulation of Immune Responses by mTOR
2012
A review of the current use of rituximab in autoimmune diseases
2008
Siglec-G–CD24 axis controls the severity of graft-versus-host disease in mice
2014
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages
2013
mTOR, metabolism, and the regulation of T‐cell differentiation and function
2012
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy
2015
Friends Not Foes: CTLA-4 Blockade and mTOR Inhibition Cooperate during CD8+ T Cell Priming To Promote Memory Formation and Metabolic Readiness
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Cutting Edge: Rapamycin Augments Pathogen-Specific but Not Graft-Reactive CD8+ T Cell Responses
2010

Works of Hēth Turnquist being referenced

IL-1β-Driven ST2L Expression Promotes Maturation Resistance in Rapamycin-Conditioned Dendritic Cells
2008
The Interface Between Tapasin and MHC Class I Identification of Amino Acid Residues in Both Proteins That Influence Their Interaction
2002
Immunoregulatory functions of mTOR inhibition
2009
Rapamycin Augments Human DC IL-12p70 and IL-27 Secretion to Promote Allogeneic Type1 Polarization Modulated by NK Cells
2013
mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo
2015
Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance
2007
Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction
2013
IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival
2011
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS
2010
Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
2014
The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
2002
Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
2012
IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells
2014
Rankless by CCL
2026